Shares of Waldencast plc (NASDAQ:WALD – Get Free Report) fell 3.9% during trading on Thursday . The stock traded as low as $5.39 and last traded at $5.39. 498 shares were traded during mid-day trading, a decline of 99% from the average session volume of 67,966 shares. The stock had previously closed at $5.61.
Wall Street Analyst Weigh In
Separately, Telsey Advisory Group decreased their price target on shares of Waldencast from $12.00 to $10.00 and set an “outperform” rating for the company in a research report on Friday, March 22nd.
View Our Latest Stock Report on WALD
Waldencast Stock Performance
Institutional Investors Weigh In On Waldencast
Several institutional investors have recently modified their holdings of the company. California State Teachers Retirement System lifted its position in shares of Waldencast by 19.4% during the 3rd quarter. California State Teachers Retirement System now owns 7,958 shares of the company’s stock worth $75,000 after purchasing an additional 1,291 shares during the last quarter. Amalgamated Bank lifted its position in shares of Waldencast by 68.1% during the 3rd quarter. Amalgamated Bank now owns 3,277 shares of the company’s stock worth $31,000 after purchasing an additional 1,328 shares during the last quarter. UBS Group AG lifted its position in shares of Waldencast by 295.8% during the 1st quarter. UBS Group AG now owns 3,297 shares of the company’s stock worth $33,000 after purchasing an additional 2,464 shares during the last quarter. Goldman Sachs Group Inc. lifted its position in shares of Waldencast by 12.0% during the 4th quarter. Goldman Sachs Group Inc. now owns 26,009 shares of the company’s stock worth $285,000 after purchasing an additional 2,793 shares during the last quarter. Finally, Legal & General Group Plc purchased a new stake in shares of Waldencast during the 3rd quarter worth $28,000. 41.97% of the stock is owned by hedge funds and other institutional investors.
About Waldencast
Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
Recommended Stories
- Five stocks we like better than Waldencast
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Comprehensive Analysis of PayPal Stock
- What is the S&P 500 and How It is Distinct from Other Indexes
- Intuitive Surgical Stock Can Trend Much Higher This YearÂ
- How to Invest in the Best Canadian StocksÂ
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.